Although the expression of mesenchymal markers or PD-L1 has been previously demonstrated in CTCs from patients with breast cancer [4,12,23,24,45], the co-expression of these markers at the single CTC level has not been reported so far. This evidence concerns the gene CD274 and breast carcinoma.